PATENT CLAIM ANALYSIS

Application Number: 16011723
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "411000"]

Abstract:
The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.

Claim (Index 6):
The method according to  claim 5 , wherein said PTGDR-2 antagonist has formula (VIII) wherein R1 is H, fluorine, methyl, methoxy, benzyloxy, or hydroxyl, R2 is phenyl which is substituted by fluorine, chlorine, trifluoromethyl, methyl, ethyl, propyl, isopropyl, or methoxy, and Y is 0 or 1, or pharmaceutically acceptable salts thereof.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.57692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15498202', '13989744', '15234754', '14192911', '14114733']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7367884114574047
- 35 USC 102 Novelty (BERT): 0.541671127691257
- Combined Prediction Score: 0.71727668308079
- Mean Citation Score: 261.078156
- Max Citation Score: 355.7615
- Similarity Product: 202.1134855440259

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test